$Cara Therapeutics Inc ($CARA) is Trading Higher on Unusual Volume for February 29
Equities Staff | Monday, 29 February 2016 16:32 (EST)
Cara Therapeutics Inc (CARA) experienced unusually high volume on Feb. 29, as the stock gained 2.63% to a closing price of $4.89. The stock saw 1.03 million shares trade hands over the course of the day on 4,623 trades. Given that the stock’s average daily volume over the last month has been 496,122 shares a day, this represents a pretty substantial spike over the norm.
Cara Therapeutics Inc has a P/B ratio of 1.17. The stock has traded between $23.61 and $4.26 over the last 52-weeks, its 50-day SMA is now $11.36, and its 200-day SMA $14.50.
Cara Therapeutics Inc is a clinical-stage biopharmaceutical company developing and commercializing new chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors.
Headquartered in Shelton, CT, Cara Therapeutics Inc has 15 employees and is currently under the leadership of CEO Derek T. Chalmers.
For a complete fundamental analysis analysis of Cara Therapeutics Inc, check out Equities.com’s Stock Valuation Analysis report for CARA. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
THE IMPORTANCE OF THE RUSSELL 3000
The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.
With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.
For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer
Equities Staff | Monday, 29 February 2016 16:32 (EST)
Cara Therapeutics Inc (CARA) experienced unusually high volume on Feb. 29, as the stock gained 2.63% to a closing price of $4.89. The stock saw 1.03 million shares trade hands over the course of the day on 4,623 trades. Given that the stock’s average daily volume over the last month has been 496,122 shares a day, this represents a pretty substantial spike over the norm.
Cara Therapeutics Inc has a P/B ratio of 1.17. The stock has traded between $23.61 and $4.26 over the last 52-weeks, its 50-day SMA is now $11.36, and its 200-day SMA $14.50.
Cara Therapeutics Inc is a clinical-stage biopharmaceutical company developing and commercializing new chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors.
Headquartered in Shelton, CT, Cara Therapeutics Inc has 15 employees and is currently under the leadership of CEO Derek T. Chalmers.
For a complete fundamental analysis analysis of Cara Therapeutics Inc, check out Equities.com’s Stock Valuation Analysis report for CARA. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
THE IMPORTANCE OF THE RUSSELL 3000
The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.
With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.
For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
